ARA-290 has a well-developed body of peer-reviewed pre-clinical and clinical research literature: Brines M et al
Primary Peptides for Disease Reversal Retatrutide The next generation of metabolic peptides, Retatrutide is a triple agonist (GLP-1, GIP, and glucagon receptor) that produces profound metabolic effects including significant fat loss, improved insulin sensitivity, and enhanced energy expenditure
This article does not constitute medical advice
The peptide doesnt affect hormone levels, blood sugar, or IGF-1 production
Safety: Preclinical studies show low toxicity across animal models (PubMed 32334036)
Properly replenishing it after training supports the restoration of energy stores and the body's recovery Glucose is a key energy source for the muscles and the nervous system, especially important during physical effort